Bruno, Savino
 Distribuzione geografica
Continente #
NA - Nord America 1296
EU - Europa 484
AS - Asia 66
AF - Africa 2
OC - Oceania 1
Totale 1849
Nazione #
US - Stati Uniti d'America 1291
GB - Regno Unito 164
IT - Italia 103
DE - Germania 77
SE - Svezia 72
TR - Turchia 27
IN - India 23
UA - Ucraina 22
BG - Bulgaria 13
BE - Belgio 11
CN - Cina 10
FR - Francia 8
RU - Federazione Russa 4
CA - Canada 3
AL - Albania 2
BZ - Belize 2
MY - Malesia 2
PL - Polonia 2
RO - Romania 2
ZA - Sudafrica 2
AM - Armenia 1
AT - Austria 1
AU - Australia 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
Totale 1849
Città #
Fairfield 250
Southend 139
Woodbridge 134
Chandler 130
Seattle 112
Ashburn 100
Houston 97
Wilmington 82
Cambridge 72
Ann Arbor 68
Modena 66
Nyköping 50
Dearborn 41
Jacksonville 32
Izmir 24
San Diego 17
Bremen 14
Princeton 13
Sofia 13
Brussels 11
Grafing 11
Des Moines 8
Eugene 8
Redwood City 8
Augusta 4
Beijing 4
Fremont 3
Monmouth Junction 3
Mumbai 3
Rome 3
San Mateo 3
Belize City 2
Boardman 2
Chicago 2
Dallas 2
Jinan 2
Lanzhou 2
Leawood 2
London 2
Muizenberg 2
Amsterdam 1
Apo 1
Ardabil 1
Ascoli Piceno 1
Birmingham 1
Citta 1
Cividale Del Friuli 1
Clearwater 1
Indiana 1
Los Angeles 1
Markham 1
Milan 1
Modesto 1
Montréal 1
Naples 1
Napoli 1
Novokuznetsk 1
Ottawa 1
Padova 1
Pontevedra 1
Reggio Emilia 1
Reggio Nell'emilia 1
Rho 1
San Francisco 1
Shaoxing 1
Sydney 1
Targu 1
Tokyo 1
Torino 1
Vienna 1
Yerevan 1
Totale 1572
Nome #
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 273
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 250
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 244
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 179
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 177
From current status to optimization of HCV treatment: Recommendations from an expert panel 141
Current and future challenges in HCV: insights from an Italian experts panel 135
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 131
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 96
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 93
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 77
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 58
Preoperative Risk Factors for Access Site Failure in Ultrasound-Guided Percutaneous Treatment of TASC C and D Aorto-Iliac Occlusive Disease 24
Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study 4
Totale 1882
Categoria #
all - tutte 3448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201837 0000 00 015 7942
2018/2019243 9368 1215 196 14165283
2019/2020361 308918 3385 6133 4115217
2020/2021639 29154149 9761 13850 27704814
2021/2022305 2022919 724 2027 31336231
2022/2023266 46483339 4248 100 0000
Totale 1882